Blansko, Czechia

Oldrich Smekal

This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Synthon B.v.. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Oldrich Smekal. Retrieved from https://idiyas.com/inventor/oldrich-smekal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Oldrich Smekal: Innovator in Pharmaceutical Processes

Introduction

Oldrich Smekal is a notable inventor based in Blansko, Czech Republic. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for the preparation of important compounds.

Latest Patents

Oldrich Smekal holds two patents, both related to the process for making palbociclib. The first patent describes a method for preparing palbociclib, where an intermediate compound is formed by reacting specific compounds in a solvent mixture of methanol and butanol. The second patent also focuses on the preparation of palbociclib and introduces a solid crystalline form of the intermediate used in the process.

Career Highlights

Oldrich Smekal is associated with Synthon B.V., a company known for its innovative approaches in the pharmaceutical industry. His work has contributed to advancements in drug development, particularly in oncology.

Collaborations

He has collaborated with notable coworkers, including Petr Mitas and Libor Vyklicky, who have also contributed to the field of pharmaceutical innovations.

Conclusion

Oldrich Smekal's work in the preparation of palbociclib showcases his expertise and dedication to advancing pharmaceutical processes. His contributions are significant in the ongoing development of effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…